Stocks & Investing
Stocks and Investing
Stocks and Investing
Thu, September 14, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Wed, September 13, 2023
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
[ 12:00 AM ] - United States, WOPRAI
Hans Mosesmann Reiterated (AIP) at Strong Buy and Held Target at $21 on, Sep 13th, 2023
Hans Mosesmann of Rosenblatt, Reiterated "Arteris, Inc." (AIP) at Strong Buy and Held Target at $21 on, Sep 13th, 2023.
Hans has made no other calls on AIP in the last 4 months.
There is 1 other peer that has a rating on AIP. Out of the 1 peers that are also analyzing AIP, 0 agree with Hans's Rating of Hold.
This is the rating of the analyst that currently disagrees with Hans
- Gus Richard of "Northland Capital Markets" Maintained at Buy with Decreased Target to $14 on, Wednesday, September 6th, 2023
